Science should save all, not just some.

The article critiques the legacy of colonialism in scientific research, emphasizing how intellectual property and access inequalities disproportionately benefit Global North countries and corporations. Topics discussed include the failure of equitable COVID-19 vaccine distribution, the high cost and limited access to breakthrough Human Immunodeficiency Virus (HIV) prevention treatments, and the need for Global South nations to lead and reform scientific equity and access.